SIVA, a target of p53, is downregulated in myelodysplastic syndromes (2017)
- Authors:
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1186/s41241-017-0033-9
- Subjects: LEUCEMIA; MEDULA ÓSSEA; EXPRESSÃO GÊNICA
- Keywords: SIVA1; SIVA2; Myelodysplastic syndromes; TP53; MDM2
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Applied Cancer Research
- ISSN: 1980-5578
- Volume/Número/Paginação/Ano: v. 37, art. 25, 7 p., 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MACHADO NETO, João Agostinho et al. SIVA, a target of p53, is downregulated in myelodysplastic syndromes. Applied Cancer Research, v. 37, p. 7 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s41241-017-0033-9. Acesso em: 01 mar. 2026. -
APA
Machado Neto, J. A., Campos, P. de M., Favaro, P., Lazarini, M., Scopim-Ribeiro, R., Lorand-Metze, I., et al. (2017). SIVA, a target of p53, is downregulated in myelodysplastic syndromes. Applied Cancer Research, 37, 7 . doi:10.1186/s41241-017-0033-9 -
NLM
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Scopim-Ribeiro R, Lorand-Metze I, Costa FF, Saad STO, Traina F. SIVA, a target of p53, is downregulated in myelodysplastic syndromes [Internet]. Applied Cancer Research. 2017 ; 37 7 .[citado 2026 mar. 01 ] Available from: https://doi.org/10.1186/s41241-017-0033-9 -
Vancouver
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Scopim-Ribeiro R, Lorand-Metze I, Costa FF, Saad STO, Traina F. SIVA, a target of p53, is downregulated in myelodysplastic syndromes [Internet]. Applied Cancer Research. 2017 ; 37 7 .[citado 2026 mar. 01 ] Available from: https://doi.org/10.1186/s41241-017-0033-9 - Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412
- FMNL1 promotes proliferation and migration of leukemia cells
- SF3B1 mutations are infrequently found in non-myelodysplastic bone marrow failure syndromes and mast cell diseases but, if present, are associated with the ring sideroblast phenotype
- IRS1 (insulin receptor substrate 1)
- Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia
- IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients
- Hedgehog pathway is deregulated in myelodysplastic syndrome progenitor bone marrow cells
- Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome
Informações sobre o DOI: 10.1186/s41241-017-0033-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
